Khan, S, Burt, D, Ralph, C, Hawkins, R, Elkord, E, "Tremelimumab (anti-CTLA4) mediates immune responses mainly by direct activation of T effector cells rather than by affecting T regulatory cells", Clinical Immunology, 2011